,10 Given the chromosomal proximity of MTAP to the CDKN2A locus and the high frequency of concurrent deletions,11 MTAP IHC loss has been suggested as an alternative to evaluate for CDKN2A HD in different CNS and non-CNS tumors, including a recent study in PXA.12–15. This evidence concerns the gene MTAP and central nervous system neoplasm.